Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 21, 2021

View Archived Issues

Hongyun Biotech identifies new EGFR inhibitors

New ATR kinase inhibitors discovered at Shenzhen Life Fountain Biotech

Researchers unveil ACOT13, PTGER2 as candidate genes of autosomal dominant polycystic kidney disease

GTPase KRAS mutant inhibitors patented by Genfleet Therapeutics

Biopolar Hongye presents new Janus kinase inhibitors

JAK inhibitors divulged by Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical

CLIP-170S confers resistance to taxane-based therapy in gastric cancer

IpY.20 targets p27Kip1 to evade breast cancer resistance driven by CDK4 and CDK2

MCC-1734 inhibits cancer cells with different resistance mechanisms

Mouse model of metaplastic breast cancer with conditional overexpression of TRIM24

Novel XO inhibitors show efficacy in acute hyperuricemia rat model

P38 targeting reverses immunosuppressive tumor microenvironment in metastatic breast cancer

FibroGen exercises license option for HiFiBiO's anti-CCR8 monoclonal antibody program

IFI27 as a potential new gene biomarker for severe COVID-19

Aridis' AR-701 is broadly reactive against Omicron and other SARS-CoV-2 variants

RaQualia and Hisamitsu to enter license agreement for sodium channel blocker

Choline transporter in fruit fly brain tunes out unnecessary information

Extension of Series A financing at Ambys supports progression of AMI-918 for liver disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...